Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p21ras in carcinogenesis

J E de Vries1, J ten Kate, F T Bosman

  • 1Department of Physiology, University of Limburg, Maastricht, The Netherlands.

Pathology, Research and Practice
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collagen content and distribution in the normal and transplanted human heart: A postmortem quantitative light microscopic analysis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer.

British journal of cancer·2013
Same author

The serrated polyp: getting it right!

Journal of clinical pathology·2010
Same author

Altered expression of CD44 and DKK1 in the progression of Barrett's esophagus to esophageal adenocarcinoma.

Virchows Archiv : an international journal of pathology·2009
Same journal

A novel oxygen-releasing bilayer delivery system for cell survival and peripheral nerve regeneration.

Pathology, research and practice·2026
Same journal

Autophagy modulation in ulcerative colitis with traditional Chinese medicine: A review.

Pathology, research and practice·2026
Same journal

Ras signalling in infectious disease pathology: Mechanisms, tissue damage, and clinical implications.

Pathology, research and practice·2026
Same journal

CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction.

Pathology, research and practice·2026
Same journal

Multifactorial pathophysiology of varicocele: Integrating hemodynamic, oxidative, and endocrine mechanisms.

Pathology, research and practice·2026
Same journal

Comparative pathophysiology and pathology of transient ischemic attack, ischemic stroke, and reperfusion injury: Mechanistic and therapeutic perspectives.

Pathology, research and practice·2026
See all related articles

Constitutively activated p21Ras oncoproteins promote cell proliferation and suppress apoptosis, disrupting cell cycle regulation. This dysregulation contributes to early carcinogenesis by unbalancing cell growth and death pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • p21Ras proteins are crucial in signal transduction pathways regulating cell proliferation, apoptosis, and the cell cycle.
  • Oncogenic mutations in p21Ras lead to constitutive activation, favoring cell growth over cell death.

Purpose of the Study:

  • To review the role of p21Ras proteins in signal transduction pathways controlling proliferation and apoptosis.
  • To discuss the implications of p21Ras oncoprotein-mediated dysregulation in early carcinogenesis.

Main Methods:

  • Literature review of studies on p21Ras function in cell signaling.
  • Analysis of the impact of oncogenic p21Ras on cell cycle and apoptosis pathways.

Main Results:

Related Experiment Videos

  • Activated p21Ras proteins stimulate proliferation by activating downstream effectors involved in cell division.
  • p21Ras oncoproteins suppress apoptosis and disrupt cell cycle control, leading to uncontrolled cell growth.
  • Dysregulated signaling pathways driven by p21Ras oncoproteins are implicated in the initiation of cancer.

    • Conclusions:

    • p21Ras proteins are central regulators of cell proliferation, apoptosis, and cell cycle.
    • Oncogenic p21Ras activation drives carcinogenesis through sustained proliferation and impaired cell death.
    • Understanding p21Ras signaling is critical for targeting early stages of cancer development.